Pharmacy Group

The UKMS Pharmacy Group was established in the Summer of 2021, with the inaugural meeting of the core steering group taking place in January 2022.

The aim of the Group is to promote excellence in the pharmaceutical care of patients with myeloma.

It will support education, development of guidelines and encourage cancer pharmacists to undertake high quality, audit and research (aligned with UKMS and UK MRA workplans).  The group will aim to support standardisation of clinical pharmacy practice across the UK.   Initial areas of focus will be the use of direct oral anticoagulants as imid thromboprophylaxis and the use of bile acid sequestrants for lenalidomide induced diarrhoea.  Other areas of focus will be delivering myeloma treatments at home and producing standardised medicine administration charts to support patients with complex myeloma treatments.

The Group will also establish a network of pharmacists with a specialist interest in myeloma across the UK. This will provide increased opportunity for peer support and encourage sharing of good clinical practice.

Group members

Catherine Loughran


Andrea Preston

Founder and Past Chair

Chris Salmen

Anish Tailor

Angharad Atkinson

Audit and research lead

Peter Baker

Rachel Senior


Grant Mehrjou

Hannah Miller

Francesca McArthur

Agendas, minutes and notifications of future meetings will be available on the UKMS and BOPA Specialist Group websites. 

For any queries please or if interested in joining the group contact Catherine Loughran (Chair) at or Andrea Preston (Past Chair) at

Andrea Preston

Catherine Loughran

Pinkie Chambers

Fleur Harvey

Chris Salmen

Aoife Tobin

Faouzi Djebbari

Anish Talor

Dunsi Bolarinwa

Angharad Atkinson

Peter Baker

Janice Chase

Noriko Kendall

Elizabeth Davies

May Low

Rebecca Burgoyne